(Q36187267)

12 August 2017

1 reference

title

Monoamine oxidase inhibitors and atypical antidepressants (English)

1 reference

12 August 2017

Monoamine Oxidase Inhibitors and Atypical Antidepressants (English)

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

13 October 2022

author name string

C. Salzman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1600483

13 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1600483

13 October 2022

publication date

1 May 1992

1 reference

full work available at URL

12 August 2017

https://api.elsevier.com/content/article/PII:S0749069018304841?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

https://api.elsevier.com/content/article/PII:S0749069018304841?httpAccept=text/plain

13 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

Clinics in geriatric medicine

13 October 2022

published in

1 reference

12 August 2017

volume

8

1 reference

12 August 2017

issue

2

1 reference

12 August 2017

page(s)

335-348

1 reference

Platelet MAO activity in geriatric patients with depression and dementia

12 August 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

Trazodone in late life depressive states: a double-blind multicenter study versus amitriptyline and mianserin

13 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

Fluoxetine compared with amitriptyline in elderly depression: a controlled clinical trial

13 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

Use of MAO inhibitors in elderly patients

13 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

Clinical assessment and performance tasks in depression: a comparison of amitriptyline and trazodone.

13 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

Platelet monoamine oxidase activity: demographic characteristics contribute to enzyme activity variability

13 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

Fluoxetine Versus Trazodone in Depressed Geriatric Patients

13 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

Human platelet monoamine oxidase--a useful enzyme in the study of psychiatric disorders?

13 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

Resistant geriatric depressions and therapeutic response to monoamine oxidase inhibitors

13 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients

13 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

Clinical predictors of response to antidepressants in elderly patients

13 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

Factors affecting the delay of antidepressant effect in responders to nortriptyline and phenelzine

13 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

How effective and safe is continuation therapy in elderly depressed patients? Factors affecting relapse rate

13 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

Electrocardiographic effects of nortriptyline, phenelzine, and placebo under optimal treatment conditions.

13 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

Response of depressive symptoms to nortriptyline, phenelzine and placebo.

13 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly.

13 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

The usefulness of DST in predicting response to antidepressants: a placebo-controlled study

13 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

Treatment of geriatric depression with trazodone, imipramine, and placebo: a double-blind study

13 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

Effect of Magnesium Pemoline and Methylphenidate on Memory Improvement and Mood in Normal Aging Subjects

13 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

Low-dose methylphenidate in the very old

13 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

The use of ritalin in psychotherapy of depressions of the aged

13 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

Monoamine oxidase inhibitors as treatment for depressed patients with primary degenerative dementia (Alzheimer's disease).

13 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

The use of monoamine oxidase inhibitors in the treatment of elderly, depressed patients.

13 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

Safety and efficacy of bupropion in elderly patients: preliminary observations

13 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

Trazodone. A comparative clinical and predictive study

13 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

Efficacy of phenelzine in geriatric depression

13 October 2022

41

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

Efficacy of phenelzine in geriatric depression

13 October 2022

42

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

Differential dosing of trazodone in elderly depressed patients: a study to investigate optimal dosing

13 October 2022

44

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

Changes in monoamine oxidase and monoamines with human development and aging

13 October 2022

46

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

Relation of Sex and Aging to Monoamine Oxidase Activity of Human Brain, Plasma, and Platelets

13 October 2022

47

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

Use of psychostimulants for the elderly

13 October 2022

48

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

Neuroendocrinological and clinical data upon trazodone treatment in depressed patients

13 October 2022

49

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

Cardiovascular effects of bupropion in depressed patients with heart disease.

13 October 2022

51

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

Stimulants in the treatment of depression: a critical overview

13 October 2022

60

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

Human monoamine oxidase. Lack of brain and platelet correlation

13 October 2022

65

1 reference

https://api.crossref.org/works/10.1016/S0749-0690(18)30484-1

13 October 2022

Identifiers

1 reference